FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367678861> ?p ?o ?g. }

• W4367678861 abstract "Objectives To evaluate the effects of mirabegron in the treatment of overactive bladder syndrome (OAB) after radical prostatectomy (RP). Patients and methods A total of 108 post-operative RP patients were randomly assigned to either the mirabegron (study) or the placebo (control) group. The Overactive Bladder Syndrome Self-Assessment Scale (OABSS) was selected as the primary endpoint, and the International Prostate Symptom Score (IPSS) and Quality of Life (QOL) score were selected as secondary endpoints. Statistical analysis was performed using IBM SPSS Statistics 26, and the treatment effects were compared between the two groups using independent samples t-test. Results In total, 55 patients were included in the study group and 53 patients in the control group. The mean age was(70.08 ± 7.54)years. There was no statistical difference in the baseline data between the two groups. OABSS scores decreased significantly in the study group compared to the control group during drug treatment (6.67 ± 1.06 vs. 9.14 ± 1.83, p &lt; 0.01) and were better than the control group during the follow-up at week 8 and week 12. In addition, the decrease in IPSS scores (11.29 ± 3.89 and 15.34 ± 3.54, p&lt;0.01) and the increase in QOL scores (2.40 ± 0.81 vs. 3.20 ± 1.00) were statistically significant in the study group. And the patients in the study group had better improvement in voiding symptoms and quality of life than the control group during the follow-up period. Conclusion Daily administration of 50 mg mirabegron after RP surgery significantly improved the symptoms of OAB after surgery with fewer side effects. Additional randomized controlled trials should be conducted in the future to further evaluate the efficacy and safety of mirabegron." @default.
• W4367678861 created "2023-05-03" @default.
• W4367678861 creator A5034249208 @default.
• W4367678861 creator A5040027560 @default.
• W4367678861 creator A5045232016 @default.
• W4367678861 creator A5051607146 @default.
• W4367678861 creator A5052836808 @default.
• W4367678861 creator A5055055894 @default.
• W4367678861 creator A5063514061 @default.
• W4367678861 creator A5078526038 @default.
• W4367678861 creator A5082068423 @default.
• W4367678861 date "2023-05-02" @default.
• W4367678861 modified "2023-09-29" @default.
• W4367678861 title "Efficacy and safety of mirabegron in the treatment of overactive bladder syndrome after radical prostatectomy: a prospective randomized controlled study" @default.
• W4367678861 cites W1486254512 @default.
• W4367678861 cites W1568759101 @default.
• W4367678861 cites W1573503357 @default.
• W4367678861 cites W1845042178 @default.
• W4367678861 cites W1963810625 @default.
• W4367678861 cites W1985689558 @default.
• W4367678861 cites W1996408246 @default.
• W4367678861 cites W2009611159 @default.
• W4367678861 cites W2014110087 @default.
• W4367678861 cites W2019483940 @default.
• W4367678861 cites W2033817897 @default.
• W4367678861 cites W2033901716 @default.
• W4367678861 cites W2034343992 @default.
• W4367678861 cites W2044488088 @default.
• W4367678861 cites W2052487152 @default.
• W4367678861 cites W2071604674 @default.
• W4367678861 cites W2093767304 @default.
• W4367678861 cites W2116324813 @default.
• W4367678861 cites W2118974576 @default.
• W4367678861 cites W2160396622 @default.
• W4367678861 cites W2163648824 @default.
• W4367678861 cites W2314542994 @default.
• W4367678861 cites W2330801089 @default.
• W4367678861 cites W2512875153 @default.
• W4367678861 cites W2517867742 @default.
• W4367678861 cites W2731813062 @default.
• W4367678861 cites W2740573178 @default.
• W4367678861 cites W2789437780 @default.
• W4367678861 cites W2797700527 @default.
• W4367678861 cites W2889095276 @default.
• W4367678861 cites W2896403110 @default.
• W4367678861 cites W2897848206 @default.
• W4367678861 cites W2943848532 @default.
• W4367678861 cites W3128646645 @default.
• W4367678861 cites W3135862631 @default.
• W4367678861 cites W3195984645 @default.
• W4367678861 cites W4225815773 @default.
• W4367678861 cites W4288431928 @default.
• W4367678861 cites W4296774977 @default.
• W4367678861 doi "https://doi.org/10.3389/fonc.2023.1188619" @default.
• W4367678861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37205190" @default.
• W4367678861 hasPublicationYear "2023" @default.
• W4367678861 type Work @default.
• W4367678861 citedByCount "0" @default.
• W4367678861 crossrefType "journal-article" @default.
• W4367678861 hasAuthorship W4367678861A5034249208 @default.
• W4367678861 hasAuthorship W4367678861A5040027560 @default.
• W4367678861 hasAuthorship W4367678861A5045232016 @default.
• W4367678861 hasAuthorship W4367678861A5051607146 @default.
• W4367678861 hasAuthorship W4367678861A5052836808 @default.
• W4367678861 hasAuthorship W4367678861A5055055894 @default.
• W4367678861 hasAuthorship W4367678861A5063514061 @default.
• W4367678861 hasAuthorship W4367678861A5078526038 @default.
• W4367678861 hasAuthorship W4367678861A5082068423 @default.
• W4367678861 hasBestOaLocation W43676788611 @default.
• W4367678861 hasConcept C121608353 @default.
• W4367678861 hasConcept C126322002 @default.
• W4367678861 hasConcept C126894567 @default.
• W4367678861 hasConcept C142724271 @default.
• W4367678861 hasConcept C159110408 @default.
• W4367678861 hasConcept C168563851 @default.
• W4367678861 hasConcept C203092338 @default.
• W4367678861 hasConcept C204787440 @default.
• W4367678861 hasConcept C27081682 @default.
• W4367678861 hasConcept C2776235491 @default.
• W4367678861 hasConcept C2776547966 @default.
• W4367678861 hasConcept C2778164427 @default.
• W4367678861 hasConcept C2778941218 @default.
• W4367678861 hasConcept C2779466945 @default.
• W4367678861 hasConcept C2779478474 @default.
• W4367678861 hasConcept C2779951463 @default.
• W4367678861 hasConcept C65409693 @default.
• W4367678861 hasConcept C71924100 @default.
• W4367678861 hasConceptScore W4367678861C121608353 @default.
• W4367678861 hasConceptScore W4367678861C126322002 @default.
• W4367678861 hasConceptScore W4367678861C126894567 @default.
• W4367678861 hasConceptScore W4367678861C142724271 @default.
• W4367678861 hasConceptScore W4367678861C159110408 @default.
• W4367678861 hasConceptScore W4367678861C168563851 @default.
• W4367678861 hasConceptScore W4367678861C203092338 @default.
• W4367678861 hasConceptScore W4367678861C204787440 @default.
• W4367678861 hasConceptScore W4367678861C27081682 @default.
• W4367678861 hasConceptScore W4367678861C2776235491 @default.
• W4367678861 hasConceptScore W4367678861C2776547966 @default.
• W4367678861 hasConceptScore W4367678861C2778164427 @default.
• W4367678861 hasConceptScore W4367678861C2778941218 @default.

• next